Delivery Order SPE2DB24D2205-SPE2DB25FDXUJ

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,773.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product. It is a firm fixed-price delivery order contract with a completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.82 Firm Fixed Price Delivery Order is for the supply of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a pharmaceutical product, with an ultimate completion date of February 3, 2025. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The $1,537.03 delivery order is for Tetracaine 0.5% Steri-Unit Solution 4ML, a prescription medication. The order is placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a wide range of medical commodities from...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,756.63 firm fixed-price delivery order is for the supply of Tetracaine 0.5% Steri-Unit Solution, a specialty pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,191.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564627142 ! TETRACAINE 0.5% STERI-UNIT SOL 4ML, a prescription medication, with a completion date of May 17, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of TETRACAINE 0.5% EYE 1S medication with a ceiling value of $4,133.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. The contract is not designated with a set-aside and was awarded on...
The federal contract award, with ID SPE2DB24D1021|SPE2DB25FETSF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,188.63 firm fixed-price delivery order contract is for the provision of 4567138906 TETRACAINE 0.5% STERI-UNIT SOL 4ML, with a period of performance through February 4, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $18,362.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp for the delivery of Tetracain HCL 0.5% 12S, a pharmaceutical product. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by various federal agencies, including a $999,999,999 IDC with the DLA...
This federal contract award SPE2DB22D3004 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,321.22 firm fixed-price delivery order is for the supply of 1% Tetracaine (20 mg/2 ml) vial product, with a performance period through May 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FBEE8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,477,022 units of Tetracaine 0.5% Steri-Unit solution in 4 mL containers. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,780.70 and an ultimate completion date of August 19, 2024. This award is not associated with a set-aside program....
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXUJ
    Delivery Order

This federal contract award, valued at $1,774.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product, with a completion date of February 4, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

This contract award was not designated with a set-aside requirement, indicating open competition. The contract type is Delivery Order with a Firm Fixed Price pricing structure.

Generated 5/5/25, 9:53 AM